[High Levels of Systemic Inflammatory Markers Associated with Metastasis Incidence in Osteosarcoma]
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Elevated inflammatory markers like neutrophil count, CRP, ESR, NLR, and LDH are linked to metastasis in osteosarcoma patients. These markers may help predict prognosis and guide future research into anti-inflammatory therapies.
Area Of Science
- Oncology
- Biochemistry
Background
- Osteosarcoma is a primary bone malignancy with a high propensity for metastasis.
- Identifying reliable prognostic markers is crucial for improving patient outcomes.
Purpose Of The Study
- To investigate the association between specific inflammatory markers and the presence of metastasis in osteosarcoma patients.
Main Methods
- Retrospective analysis of 40 osteosarcoma patients.
- Collected data included white blood cell differential, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH).
- Statistical analyses included Pearson's Chi-squared test, Fisher's exact test, and logistic regression.
Main Results
- Elevated neutrophil count, CRP, ESR, NLR, and LDH levels were significantly associated with metastasis.
- Odds ratios for metastasis ranged from 7.429 (NLR) to 19.000 (ESR).
Conclusions
- Neutrophil count, ESR, NLR, CRP, and LDH are significant indicators of metastasis in osteosarcoma.
- These markers hold potential as prognostic tools.
- Further research is warranted to explore underlying mechanisms and targeted anti-inflammatory therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
